Growth of OTC contracts slows to 5%, say BIS
Rising commodity prices and a worldwide rally in equity prices during the second half of last year have dramatically increased the demand for over-the-counter derivatives protection in the sectors, according to the latest statistics released by the Bank for International Settlements (BIS). But overall growth in contracts slowed somewhat compared with previous periods due to a tailing-off of demand for interest rate products.
But interest rate products, which with a notional value of $215 trillion at the end of 2005 make up by far the biggest OTC contract type, grew by only 5%. According to the BIS, these increases were modest compared with the semi-annual double-figure increases in demand for interest rate OTC contracts in the first half of the decade.
“It is still too early to say whether this slowdown in growth is temporary or of a more permanent nature, perhaps related to the maturing of the market,” said the BIS report. “What is clear is that the rates of growth in the OTC market outstrip those recorded in organised derivatives exchanges.”
The overall growth of the notional value of outstanding over-the-counter derivatives has been slowing somewhat in the previous two reports. After continuous double-figure increases, they grew by 8% in the first half of last year, down from 14% in the second half of 2004.
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe
You are currently unable to print this content. Please contact info@risk.net to find out more.
You are currently unable to copy this content. Please contact info@risk.net to find out more.
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@risk.net
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@risk.net
More on Regulation
Erba myth: will US banks choose new capital measure?
B3E gives US banks a dilemma – adopt expanded risk-based approach, or a new standardised alternative
Illiquid assets pricing still needs expert judgement, say banks
EU regulators want more transparency in valuations, but some asset prices remain elusive
Fed to move tailored-capital goalposts soon, says Bowman
Banks hope agencies will index triggers for harsher capital rules to economic growth
Will SEC reporting proposal supercharge alt data providers?
Move that would allow companies to opt out of quarterly reporting disclosures welcomed
EU lawmaker calls for review of Luxembourg’s cross-border rules
Grand Duchy accused of side-stepping rules aimed at prising away banking business from London
Un-American or un-JPM? Surcharge rethink divides G-Sibs
Some see sense in rethink to funding indicator, others call for a backtrack
Bank of England softens tone on CCP cross-product margining
Breeden supports margin efficiencies to encourage more repo clearing, but still warns on leverage
UK securitisation reforms trump EU’s, say market players
Originators and investors could find UK securitised assets easier to deal with after tandem reviews